West Virginia 2026 Regular Session

West Virginia House Bill HB 4240

Introduced
1/14/26  

Caption

Relating to authorizing the Commissioner of Financial Institutions to promulgate a legislative rule relating to the Fintech Regulatory Sandbox Program.

Summary

HB 4240 authorizes the Commissioner of Financial Institutions to promulgate a legislative rule governing the Fintech Regulatory Sandbox Program. Based on the bill caption and available context, the measure is a rule-authorizing bill rather than a substantive rewrite of the underlying program. Its purpose is to allow the agency to adopt and update administrative rules that would structure how the sandbox operates, including the conditions under which financial technology products or services may be tested in a controlled regulatory environment. The bill appears aimed at supporting innovation in financial services by giving the Commissioner authority to establish the regulatory framework for the sandbox. A fintech sandbox typically allows qualifying companies to test new products with limited regulatory relief and oversight before full market deployment. Because the bill text is not available in the provided materials, the specific rule provisions, eligibility standards, consumer protections, and reporting requirements cannot be identified from the record here.

Impact

HB 4240 would affect state administrative law by authorizing rulemaking for the Fintech Regulatory Sandbox Program, thereby enabling the Commissioner of Financial Institutions to implement or revise program standards through legislative rule. The practical impact would fall on fintech firms, financial institutions, and potentially consumers participating in or affected by sandbox testing. It would not itself appear to create the program from scratch, but rather to permit the agency to formalize the program’s operational rules under state law.

Sentiment

The available record suggests a neutral to favorable posture toward the bill, with no recorded committee transcript, debate, or vote data indicating opposition. Because the measure is a rule-authorizing bill tied to a fintech innovation program, it is likely viewed as a technical or administrative step rather than a controversial policy change. However, without hearing records, the level of support or any reservations cannot be determined with certainty.

Contention

No specific points of contention are documented in the provided materials. In similar fintech sandbox legislation, potential concerns often include consumer protection, regulatory oversight, market fairness, and whether the sandbox gives certain firms an advantage or exposes consumers to risk. If any objections existed here, they are not reflected in the available transcript or voting history.

Companion Bills

WV SB 339

Similar To Commissioner of Financial Institutions rule relating to Fintech Regulatory Sandbox Program

Previously Filed As

WV SB47

Authorizing WVSSAC to promulgate legislative rules

WV HB2227

Relating to authorizing the Department of Administration to promulgate a legislative rule relating to financial services reporting

WV HB2244

Relating to authorizing the Department of Health to promulgate a legislative rule relating to the Primary Care Support Program

WV HB2261

Relating to authorizing the Alcohol Beverage Control Commissioner to promulgate a legislative rule relating to private club licensing

WV HB2267

Authorizing Department of Revenue to Promulgate Legislative Rules

WV SB325

Authorizing Department of Health to promulgate legislative rules

WV HB2329

Relating to authorizing the Hope Scholarship Board to promulgate a legislative rule relating to Hope Scholarship Program

WV HB2262

Relating to authorizing the Alcohol Beverage Control Commissioner to promulgate a legislative rule relating to the sale of wine and hard cider

WV HB2248

Relating to authorizing the Department of Health to promulgate a legislative rule relating to dispensaries of the Medical Cannabis Program

WV HB2247

Relating to authorizing the Department of Health to promulgate a legislative rule relating to laboratories of the Medical Cannabis Program

Similar Bills

No similar bills found.